This study examined the effect of acute hyperglycaemia, induced by intravenous glucose, on gall bladder motility. Six healthy volunteers were studied in random order on three occasions during normoglycaemia and hyperglycaemia with blood glucose concentrations stabilised at 8 and 15 mmol/l. Gail bladder volumes, measured with ultrasonography, were studied before and during infusion of stepwise increasing doses of cholecystokinin 05, and 1.0 IDU.kg-1.h-1). 
(CCK-33; 0-25, 05, and 1.0 IDU.kg-1.h-1). Recently several studies have emphasised the importance of serum glucose concentrations in the regulation of gastrointestinal function. '6 In healthy subjects hyperglycaemia induced by intravenous infusion of glucose reduces gastric emptying of solid and liquid meals,' gastric acid secretion,45 and pancreatic secretion.46 Little is known, however, about the effect of hyperglycaemia on gall bladder motility. It has been suggested that hyperglycaemia reduces gastrointestinal function through inhibition of the vagal cholinergic system.2 3 This study was sulphated tryosyl region. The detection limit of the assay was 0 5 pmol/l plasma. The within assay variation ranged from 4-6% to 11-5% and the between assay variation from 11-3% to 26 1%.'5 Plasma insulin was measured by radioimmunoassay as described previously. 1 ' nique. 1211 The acute rise in blood glucose concentrations was induced by an intravenous bolus injection of a glucose 20% solution 45 minutes before the start ofCCK-33 infusion. The amount of glucose given was calculated from body weight. After a bolus injection the rate ofglucose infusion was adjusted to maintain a blood glucose concentration of about 8 or 15 mmol/l according to the protocol. Serum glucose concentrations were measured every 2 5 to five minutes by the glucose oxidase method (Beckman glucose analyser, Beckman Instruments).
At In recent years it has been possible to study the mechanisms involved in the regulation postprandial gall bladder motility in detail because of the development of sensitive and specific radioimmunoassays for measurement of CCK and the availability of ultrasonography and cholescintigraphy as non-invasive methods to measure human gall bladder motility.9 10 1518 '9 Two findings point to an important role of CCK in the regulation of postprandial gall bladder motility. Firstly, after eating a meal gall bladder contraction is closely related to plasma CCK concentrations. 1820 Secondly, intravenous infusion of CCK to plasma concentrations comparable with those found after meals induces similar gall bladder contraction.3 18 It is not known whether in patients with diabetes mellitus, as in healthy subjects, the gall bladder sensitivity to CCK is influenced by serum glucose concentrations. A reduced gall bladder emptying in response to a meal and to infusion of CCK-33 has been reported in such patients.28 This has been associated with the presence of autonomic neuropathy as in diabetic patients without neuropathy the gall bladder contraction in response to CCK is not different from that in healthy subjects. No significant correlation has been found between impaired gall bladder emptying and overall diabetic control as determined by the percentage of total haemoglobin present as glycated haemoglobin.28 It remains to be established whether in diabetic patients gall bladder motility is dependent on actual serum glucose concentrations.
In conclusion blood glucose concentrations affect gall bladder motility in healthy subjects, an acute hyperglycaemia at 8 and 15 mmol/l dose dependently reduces the gall bladder sensitivity to CCK-33, and hyperglycaemia reduces basal and CCK-33 stimulated plasma PP concentrations, suggesting impaired cholinergic activity during hyperglycaemia. 
